Cosmetic signal peptide (topical collagen stimulator)
Palmitoyl Pentapeptide-4
A widely used cosmetic peptide that available evidence suggests may support collagen production and reduce wrinkle appearance topically.
- Evidence:
- Limited human evidence
- Status:
- Not FDA-approved
- Reviewed:
- 2026-08-03
Also known as: Palmitoyl Pentapeptide-4, Pal-KTTKS
What is Palmitoyl Pentapeptide-4?
A widely used cosmetic peptide that available evidence suggests may support collagen production and reduce wrinkle appearance topically.
This profile is educational. It organizes publicly discussed research context for Palmitoyl Pentapeptide-4 and related naming aliases — it is not a treatment guide.
Proposed mechanism
Pro-collagen I fragment mimic; stimulates collagen I, III, and fibronectin synthesis in fibroblasts.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Limited human evidence
Preclinical evidence grade: Moderate human evidence
Matrixyl (palmitoyl pentapeptide-4) is among the best-studied cosmetic peptides. In vitro and small clinical studies show wrinkle reduction over weeks of topical use. Human evidence is moderate for cosmetic endpoints, not pharmaceutical claims. Standard in anti-aging skincare formulations.
Key uncertainties
- Magnitude of effect vs retinoids
- Long-term collagen histology in humans
Research areas being studied
- Skin aging
- Collagen synthesis
- Cosmetic dermatology
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Generally well tolerated topically
- Mild irritation possible
Additional risks & considerations
- Cosmetic-only evidence
- Individual response variability
- Formulation dependent
Regulatory status
Not FDA-approved
Cosmetic ingredient; not FDA approved as drug.
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Palmitoyl Pentapeptide-4?
A widely used cosmetic peptide that available evidence suggests may support collagen production and reduce wrinkle appearance topically.
How does Palmitoyl Pentapeptide-4 work (proposed mechanism)?
Pro-collagen I fragment mimic; stimulates collagen I, III, and fibronectin synthesis in fibroblasts.
What is Palmitoyl Pentapeptide-4 being researched for?
Palmitoyl Pentapeptide-4 has been discussed in research contexts including: Skin aging, Collagen synthesis, Cosmetic dermatology.
What does current evidence say about Palmitoyl Pentapeptide-4?
Limited human evidence. Matrixyl (palmitoyl pentapeptide-4) is among the best-studied cosmetic peptides. In vitro and small clinical studies show wrinkle reduction over weeks of topical use. Human evidence is moderate for cosmetic endpoints, not pharmaceutical claims. Standard in anti-aging skincare formulations.
What safety considerations are noted for Palmitoyl Pentapeptide-4?
Reported or discussed considerations include: Generally well tolerated topically; Mild irritation possible; Cosmetic-only evidence; Individual response variability; Formulation dependent. This is educational information, not medical advice.
Is Palmitoyl Pentapeptide-4 FDA approved?
Not FDA-approved. Cosmetic ingredient; not FDA approved as drug.
References & sources
- Robinson LR et al. (2005). Pal-KTTKS and collagen stimulation in skin — Int J Cosmet Sci. Evidence type: human.
Prefer interactive tools? Open the PepGuide library entry for Palmitoyl Pentapeptide-4 or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.